Soleno Therapeutics Inc. (SLNO)
NASDAQ: SLNO
· Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
72.00
0.52%
After-hours: Aug 15, 2025, 07:57 PM EDT
Soleno Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 32.66M | n/a | n/a | n/a | n/a | n/a | 3.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 696K | n/a | n/a | n/a | 494K | 490K | 489K | 557K | 598K | 568K | 519K | 565K | 563K | 563K | 516K | 561K | 565K | 565K |
Gross Profit | 31.96M | n/a | n/a | n/a | -494K | -490K | 2.96M | -557K | -598K | -568K | -519K | -565K | -563K | -563K | -516K | -561K | -565K | -565K |
Operating Income | -6.53M | -45.74M | -59.12M | -80.21M | -23.23M | -21.4M | -12.83M | -10.86M | -8.62M | -8.47M | -5.61M | -6.24M | -6.78M | 5.77M | -3M | -8.29M | -11.09M | 9.16M |
Interest Income | 3.19M | n/a | 3.37M | 3.6M | 3.01M | 2.08M | 2.14M | 174K | 147K | 113K | 125K | 101K | 52K | 22K | 34K | 34K | 41K | 1K |
Pretax Income | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.36M | -5.49M | -6.13M | -6.72M | -5.72M | -2.83M | -8.14M | -10.99M | -8.95M |
Net Income | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.35M | -3.75M | -6.29M | -7.85M | -3.91M | -2.83M | -8.14M | -10.99M | -8.95M |
Selling & General & Admin | 28.24M | 29.26M | 37.3M | 49.2M | 10.39M | 8.47M | 3.65M | 3.32M | 3.17M | 2.85M | 2.4M | 2.33M | 2.47M | 2.64M | 2.6M | 2.77M | 2.46M | 2.98M |
Research & Development | 9.15M | 13.52M | 21.49M | 30.14M | 12.34M | 14.6M | 8.69M | 6.04M | 5.14M | 5.32M | 3.81M | 3.77M | 3.7M | 3.99M | 3.73M | 4.97M | 5.59M | 7.16M |
Other Expenses | 1.1M | 2.97M | 327K | 877K | n/a | 401K | n/a | 1.02M | 313K | 299K | -132K | 132K | 616K | n/a | n/a | 551K | 3.03M | n/a |
Operating Expenses | 38.49M | 45.74M | 59.12M | 80.21M | 22.74M | 23.48M | 12.34M | 10.38M | 8.31M | 8.17M | 6.21M | 6.1M | 6.16M | 6.63M | 6.33M | 7.74M | 8.05M | 10.14M |
Interest Expense | 1.38M | -1.36M | 231K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -494K | n/a | -489K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 39.18M | 45.74M | 60.27M | 80.21M | 23.23M | 23.48M | 12.83M | 10.38M | 8.31M | 8.17M | 6.21M | 6.1M | 6.16M | 6.63M | 6.33M | 7.74M | 8.05M | 10.14M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 1.19M | 2M | -2.16M | n/a | -5K | -1.74M | 159K | 1.12M | -1.81M | n/a | n/a | n/a | -1.19M |
Shares Outstanding (Basic) | 50.48M | 46.18M | 43.92M | 41.88M | 38.63M | 36.21M | 34.39M | 11.43M | 10.42M | 9.45M | 9.44M | 9.42M | 9.34M | 5.33M | 5.32M | 5.32M | 5.32M | 5.31M |
Shares Outstanding (Diluted) | 50.48M | 46.18M | 43.92M | 41.88M | 38.63M | 36.21M | 34.44M | 11.44M | 10.42M | 9.45M | 9.44M | 9.42M | 9.34M | 5.33M | 5.32M | 5.32M | 5.32M | 5.31M |
EPS (Basic) | -0.09 | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | -0.33 | -0.95 | -0.81 | -0.88 | -0.4 | -0.67 | -0.84 | -0.73 | -0.53 | -1.53 | -2.07 | -1.69 |
EPS (Diluted) | -0.09 | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | -0.33 | -0.95 | -0.81 | -0.88 | -0.4 | -0.67 | -0.84 | -0.73 | -0.53 | -1.53 | -2.07 | -1.69 |
EBITDA | -2.83M | -41.91M | -55.25M | -78.83M | -22.74M | -22.58M | -12.34M | -8.87M | -7.88M | -7.68M | -5.72M | -5.57M | -5.67M | -6.14M | -5.84M | -7.24M | -7.56M | -9.65M |
EBIT | -3.33M | -42.41M | -55.75M | -79.33M | -23.23M | -23.07M | -12.83M | -9.36M | -8.31M | -8.36M | -6.21M | -6.1M | -6.16M | -6.63M | -6.33M | -7.74M | -8.05M | -10.14M |
Depreciation & Amortization | 502K | 504K | 503K | 500K | 494K | 490K | 489K | 557K | 598K | 568K | 519K | 565K | 563K | 563K | 516K | 561K | 565K | 565K |